Skip to main content

Table 3 OS and DFS for the whole group

From: Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery

Group

Adjuvant chemotherapy Group (n = 150)

 

Adjuvant chemo-radiotherapy Group (n = 115)

P value

3-year

5-year

3-year

5-year

OS

92.66%

84.37%

 

95.65%

89.67%

0.341

DFS

84.0%

76.70%

 

88.53%

85.54%

0.084

  1. Abbreviations: adjuvant-chemo adjuvant chemotherapy, DFS disease-free survival, OS overall survival